- Report
- October 2023
- 148 Pages
Europe
From €3086EUR$3,450USD£2,714GBP
- Report
- July 2023
- 107 Pages
From €3086EUR$3,450USD£2,714GBP
- Report
- July 2023
- 124 Pages
North America
From €3086EUR$3,450USD£2,714GBP
- Report
- July 2023
- 108 Pages
Africa, Middle East
From €3086EUR$3,450USD£2,714GBP
- Report
- July 2023
- 130 Pages
Europe
From €3086EUR$3,450USD£2,714GBP
- Report
- June 2023
- 134 Pages
Asia Pacific
From €3086EUR$3,450USD£2,714GBP
- Report
- May 2023
- 186 Pages
Global
From €3981EUR$4,450USD£3,500GBP
- Report
- February 2023
- 203 Pages
Europe
From €3086EUR$3,450USD£2,714GBP
- Report
- June 2022
- 200 Pages
Global
From €3981EUR$4,450USD£3,500GBP
- Report
- February 2022
- 198 Pages
Global
From €3981EUR$4,450USD£3,500GBP
- Report
- September 2024
- 150 Pages
Global
From €3444EUR$3,850USD£3,028GBP
€4339EUR$4,850USD£3,815GBP
- Report
- April 2023
- 150 Pages
Global
From €3444EUR$3,850USD£3,028GBP
€4339EUR$4,850USD£3,815GBP
- Report
- February 2024
- 115 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- February 2024
- 117 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- February 2024
- 118 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- April 2023
- 115 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- April 2023
- 147 Pages
Global
From €4427EUR$4,949USD£3,893GBP
- Report
- May 2023
- 147 Pages
Global
From €4427EUR$4,949USD£3,893GBP
- Report
- March 2023
- 141 Pages
Global
From €3220EUR$3,599USD£2,831GBP
- Report
- September 2024
- 150 Pages
Global
From €3534EUR$3,950USD£3,107GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more